TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up July 13, 1979
TCL Archive NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells. November 23, 2007